TrialAntimicrobial agents and chemotherapy2012

First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses.

Wendy Painter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.